Table 1.
Demographic and clinical data of the subjects.
Table 2.
Statistical differences between control and anemia subjects in two different time points (< 5 days and 5–15 days) based on CBC and other hematological parameters.
Table 3.
Complete blood count and other hematological analysis based on COVID-19 severity (< 5 days).
Table 4.
Complete blood count and other hematological analysis based on COVID-19 severity (5–15 days).
Fig 1.
Box plot diagram showing the A. N/L ratio, B. ZnPP (mmol/mol Hb), C. ZnPP/L ratio on COVID-19 severity groups.
Group 1: Moderate, Group 2: Severe.
Fig 2.
Receiver operating characteristic (ROC) curves displaying the sensitivity and specificity of NLR, ZnPP/sTFR, ZnPP/Hepcidin, ZnPP/TS, ZnPP/IL-6, ZnPP/NLR, ZnPP/L, ZnPP, ZnPP/Fe, Hb on distinguishing COVID-19 severity.
NLR: N/L Ratio, ZnPP: Zinc Protoporphyrin, sTFR: soluble Transferrin receptor, TS: Transferrin Saturation; L: Lymphocyte, Hb: hemoglobin.
Table 5.
Receiver operating characteristic (ROC) curve analysis for ZnPP and ZnPP-to-different markers along with NLR and Hb.
Table 6.
Logistic regression analysis for single predictors associated with COVID-19 severity.